Kenvue Aktie News

Kimberly-Clark is acquiring Kenvue in a $48.7 billion cash-and-stock deal. I believe the deal is likely to close, and that Kenvue stock gives folks a decent way to buy Kimberly-Clark at a discount. There is still a solid deal spread here, and I think Kimberly-Clark is undervalued as well, offering additional upside once the deal closes.

Shares of Teradyne advanced sharply as investors cheered the company's robust earnings and outlook for Teradyne's artificial intelligence compute testing business. We initiated a position in this customer relationship management software company because it enjoys a dominant market share and a wide competitive moat. We exited our position in nVent. It rallied on the prospect of increasing data c...

The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW, and ALB, have posted double-digit gains in 2025, while others lag behind. Dividend growth among Aristocrats averages 5.46% for 2025, with most constituents announcing increases, though growth is s...

Shares of Teradyne advanced sharply as investors cheered the company's robust earnings and outlook for Teradyne's artificial intelligence compute testing business. Shares of Henry Schein declined as promotional activity to attract new customers in its online channel pressured margins. We exited our position in Centene and reallocated proceeds to other positions that we believed offered more att...

A U.S. appeals court is expected to hear arguments on Monday from families seeking to revive their lawsuits over Tylenol, after the Trump administration publicly promoted their claims that the popular painkiller is linked to autism in children.

A Texas state judge won't block Kenvue from paying its scheduled November 26 shareholder dividend, rejecting a request by Texas Attorney General Ken Paxton, a Kenvue lawyer told Reuters on Friday.

A Texas judge on Friday will consider state Attorney General Ken Paxton's bid to block Kenvue from paying a $398 million dividend to shareholders and from marketing Tylenol as safe for pregnant women.

The article reviews the November 2025 Dividend Kings, highlighting 56 stocks with long dividend growth records and recent changes to the list. Six Dividend Kings - MO, UVV, HRL, KVUE, CDUAF, UBSI - are currently fairly priced, with annual dividends from $1,000 invested meeting or exceeding share prices. Analyst forecasts suggest top-yielding Kings could deliver net gains of 18.55% to 101.43% by...